Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

2.12
Delayed Data
As of Jul 29
 +0.02 / +0.95%
Today’s Change
1.62
Today|||52-Week Range
4.27
-20.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues3.8M3.5M4.2M1.7M
 
 
 
 
 
Cost of Goods Sold3.1M4.2M1.6M695.8K
 
 
 
 
 
Depreciation And Amortization583.9K407.1K310.7K193.4K
 
 
 
 
 
 
Operating ExpensesGross Income174.0K-1.2M2.3M786.5K
 
 
 
 
 
General Expenses14.1M13.2M12.5M9.9M
 
 
 
 
 
Research And Development4.0M3.4M2.9M2.3M
 
 
 
 
 
Total Operating Expenses17.8M17.9M14.4M10.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.0M-14.4M-10.2M-9.1M
 
 
 
 
 
Extraordinary Credit5.3M--0.00--
 
 
Extraordinary Charge-108.4K---323.9K-371.7K
 
 
 
 
Interest Expense On Debt47.0K39.8K683.2K220.5K
 
 
 
 
 
Equity In Earnings-137.2K-446.9K-332.9K0.00
 
 
 
 
Other Expenses2.8M4.9M1.8M2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.4M-9.3M-9.3M-7.4M
 
 
 
 
 
Income Taxes0.00-185.0K-329.0K-92.6K
 
 
 
 
Minority Interest-9.7K-52.2K-8.5K0.00
 
 
 
 
Net Income-5.5M-9.5M-9.3M-7.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.1M3.1M3.8M7.2M
 
 
 
 
 
Shares To Calculate EPS Diluted3.1M3.1M3.8M7.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.79-$3.02-$2.42-$1.02
 
 
 
 
 
EPS Diluted-$1.79-$3.02-$2.42-$1.02